| Sr No |
Title |
Journal |
| 1. |
Reversal of Slow-Flow or No-Reflow during PTCA using boluses of IC adenosine and sodium nitroprusside, in combination |
J Am Coll Cardiol 2003;41(6 Suppl. A):561-568
|
| 2. |
Reversal of Slow-Flow or No-Reflow during PTCA using boluses of IC adenosine and sodium nitroprusside in combination |
J Am Coll Cardiol 2003;41(6 Suppl. A):1101-201.
|
| 3. |
Beneficial effects of distal protection device in Reducing the use of intracoronary vasodilators And glycoprotein IIb/IIIa receptor antagonists. During percutaneous coronary interventions. |
Catheterization and Cardiovascular Interventions 2004; 62: pg 90. (Abstract)
|
| 4. |
Improvement in mace by sequential administration Of boluses of intracoronary adenosine and sodium. Nitroprusside during percutaneous coronary Interventions .
|
Catheterization and Cardiovascular Interventions 2004; 62:130-131
|
| 5. |
Effect of Folate Treatment on Homocysteinemia in Cardiac Patients: A Prospective Study |
Indian J Pharmacol 2005; 37:13-17.
|
| 6 |
First in Man: non invasive measurement of variation in Pulmonary artery pressure following exercise in heart failure patients using an innovative implantable device involving acoustic telemetry. |
Eur Heart J 2006;27(suppl 1): 827-985
|
| 7. |
First In Man: Measurement of Diurnal Variation in Pulmonary Artery Systolic and Diastolic Pressure in Heart Failure Patients Using an Innovative Implantable Device Responding to Ultrasonic Signals |
Eur Heart J 2006;27(suppl 1): 291-565.
|
| 8. |
Effect of Metoprolol CR/XL on Exercise Capacity and Subsequent Variation in Pulmonary Artery Pressure in Heart Failure Patients Using an Innovative Implant Involving Acoustic Telemetry. |
Eur Heart J 2006;27(suppl 1): 827-985
|
| 9. |
First In Man Non-Invasive Monitoring of Pulmonary Artery Pressure from an Implantable Device Using Acoustic Telemetry: A One Year Follow-Up Data |
Eur Heart J 2006;27(suppl 1): 1-290
|
| 10. |
Measuring Pulmonary Artery Pressure Non-invasively with Conventional Contrast Echocardiography in Congestive Heart Failure. |
Eur Heart J 2006;27(suppl 1): 1-290
|
| 11. |
First-in-man: Coronary Sinus Narrowing with a Reducer Stent- A Possible Alternative Percutaneous Treatment for Patients with Refractory Angina |
J Am Coll Cardiol 2006;47;1B-56B
|
| 12. |
First in Human Implanted Device in Pulmonary Artery Using Acoustic Telemetry Based on Non-Invasive Ultrasound Activation and Communication. |
J Am Coll Cardiol 2006;47;1B-56B.
|
| 13. |
Intraconory Boluses of Adenosine and Sodium Nirtoprusside in combination Reverses Slow/No Reflow During Angioplasty: A Clinical Scenario of Experimental Pre-conditioning. |
J Am Coll Cardiol 2006;47:381A-384A
|
| 14. |
Wireless Acoustic Communication With a Miniature Pressure Sensor in the Pulmonary Artery for Disease Surveillance and Therapy of Patients With Congestive Heart Failure |
J Am Coll Cardiol 2007;49:784 – 789
|
| 15. |
Coronary Sinus Reducer-Stent for the Treatment of Chronic Refractory Angina Pectoris: A prospective, open label, multi-center safety feasibility first-in-man study. |
J Am Coll Cardiol 2007;49:1783-1789.
|
| 16 |
Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning. |
Can J Physiol Pharmacol 2007;85 (3-4):476-82.
|
| 17. |
Systemic Primary Aspiration in Acute Myocardial Percutaneous Intervention: A Multicentre Randomized controlled trial of the export aspiration catheter. |
Euro Intervention 2008;4:222-228
|
| 18. |
Effect of Metoprolol CR/XL on Pulmonary Artery Pressure in Chronic Heart Failure Patients Assessed by an Implanted Ultrasonic Device with Special Emphasis on Diurnal Variation and Exercise Capacity |
Indian Heart J 2009;61:34-9
|
| 19. |
Ovalum CiTop™ Expander™: a novel guidewire for crossing coronary chronic total occlusions – first-in-man (FIM) experience |
EuroIntervention 2009;5:206-211
|
| 20. |
Safety and Effectiveness of the Endeavor Zotarolimus-Eluting Stent in Real-World Clinical Practice: Extended 12-Month data from the E-Five Registry |
JACC Cardiovasc Interv 2009;2(12):1227-35
|
| 21. |
Platelet Inhibition with Cangrelor in Patients Undergoing PCI |
N Engl J Med 2009;361:2318-29.
|
| 22. |
Rationale and design of the Patient Related Outcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation |
Am Heart J 2009;158:902-909.e5
|
| 23. |
Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: A placebo-controlled trial (TRUST – 2) |
J Heart Lung Transplant 2010;29(2):137-49
|
| 24. |
Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial |
Circulation 2010;122:1056-1067
|
| 25. |
Pre Treatment with thienopyridines reduces the amount of Myonecrosis in acute coronary syndrome patients invasively managed: insights from the champions trials. |
Circulation 2010;122:A14183
|
| 26 |
Long-Term Follow-Up to Evaluate the Safety of the Neovasc Reducer a Device-Based Therapy for Chronic Refractory Angina.
|
J Am Coll Cardiol 2010;55;A98.E927
|
| 27. |
Six Month Follow Up Data of Orbital Atherectomy System for the Treatment of De Novo Calcified Coronary Lesions (ORBIT I Trial). |
J Am Coll Cardiol 2011;58:B172-B173
|
| 28. |
Two Year Follow Up Data of Orbital Atherectomy System for the Treatment of De Novo Calcified Coronary Lesions – A Single Center Experience. |
J Am Coll Cardiol 2011;58:B174
|
